References
- Catravas J D, Waters I W. Acute cocaine intoxication in the conscious dog: Studies on the mechanism of lethality. J Pharmacol Exp Ther 1981; 217:350–356., [PUBMED], [INFOTRIEVE], [CSA]
- Marzuk P M, Tardiff K, Leon A C, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA 1998; 279:1795–1800., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sun H, Shen M L, Pang Y P, Lockridge O, Brimijoin S. Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J Pharmacol Exp Ther 2002; 302:710–716., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Duysen E G, Bartels C F, Lockridge O. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity. J Pharmacol Exp Ther 2002; 302:751–758., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Juhascik M, Le N L, Tomlinson K, Moore C, Gaensslen R E, Negrusz A. Development of an analytical approach to the specimens collected from victims of sexual assault. J Anal Toxicol 2004; 28(6):400–406., [PUBMED], [INFOTRIEVE], [CSA]
- Negrusz A, Goldstein P J, Levy P S. Estimate of the incidence of drug-facilitated sexual assault in the United States. Proceedings of the 39th Annual The International Association of Forensic Toxicologists (TIAFT) Meeting, August, 2001, PragueCzech Republic.
- McGregor M J, Lipowska M, Shah S, et al. An exploratory analysis of suspected drug-facilitated sexual assault seen in a hospital emergency department. Women Health 2003; 37(3):71–80., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moreton R, Bedford K. Spiked drinks: A focus group study of young women's perceptions of risk and behaviours. Central Sydney Area Health Service, , Available at: www.cs.nsw.gov.au/pophealth/dph/women/projects.
- Nordenberg T. Raising consciousness about drugs and rape. FDA Consumer. Mar 1, 2000., [CSA]
- Hindmarch I, ElSohly M, Gambles J, et al. Forensic urinalysis of drug use in cases of alleged sexual assault. J Clin Forensic Med 2001; 8:197–205., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hansson R. Western Australia Chemistry Centre Annual Review 2002–03; presented July 17th, 2003 at the Australasian Drug Strategy Conference in Alice Springs, Australia.
- Date-rape druggings rare, scientists find. New Zealand Herald September 1, 2003.
- Traub S J, Hoffman, R S, Nelson L S. Body packing-The internal concealment of illicit drugs. N Eng J Med 2003; 349:2519–2526., [CSA], [CROSSREF]
- Deitel M, Syed A K. Intestinal obstruction by an unusual foreign body. Can Med Assoc J 1973; 109:211–212., [PUBMED], [INFOTRIEVE], [CSA]
- Bogusz M J, Althoff H, Erkens M, et al. Internally concealed cocaine: Analytical and diagnostic aspects. J Forensic Sci 1995; 40:811–815., [PUBMED], [INFOTRIEVE], [CSA]
- Gill J R, Graham S M. Ten years of body packers in New York City: 50 deaths. J Forensic Sci 2002; 47:843–846., [PUBMED], [INFOTRIEVE], [CSA]
- McCarron M M, Wood J D. The cocaine body packer syndrome: Diagnosis and treatment. JAMA 1983; 250:1417–1420., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Utecht M J, Stone A F, McCarron M M. Heroin body packers. J Emerg Med 1993; 11:33–40., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Afshar M, Hosniam H, Aboul-Massoomi Z, et al. The study of suspicious cases of body smuggling in Laghman hospital 1999–2000. Arch Iranian Med 2002; 5:205–206., [CSA]
- Hergan K, Kofler K, Oser W. Drug smuggling by body packing: what radiologists should know about it. Eur Radiol 2004; 14:736–742., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Heinemann A, Miyaish S, Iwersen S, et al. Body packing as cause of unexpected sudden death. Forensic Sci Int 1998; 92:1–10., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McElhatton P. The effects of drug misuse in pregnancy. In: Philips R, ed. Children exposed to substance misuse—implications for family placement. BAAF publication, 2004, pp. 43–72.
- ONS Report: Tobacco, alcohol and drug use and mental health. HMSO (2002)., [CSA]
- , Home office on-line report 33/03. 2003, [CSA]
- National Institute of Drug Abuse (NIDA). Info facts. US Department of Health. March, 2004.
- http://www.drugscope.org.uk/druginfo/drugsearch , DrugScope. FAQs December 2004.
- Bateman D N, McElhatton, P R, Dickinson D, et al. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. EJCP 2004; 60(9):635–641., [CSA], [CROSSREF]
- Turning Point, Alcohol and Drugs Centre. Victoria, Australia. December, 2003.
- McElhatton P R, Bateman D N, Evans C, Pughe, K R, Thomas, S HL. Congenital anomalies after pre-natal ecstasy exposure. Lancet 1999; 354:1441–1442., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McElhatton P, Hedgley C, Thomas S. Congenital anomalies after pre-natal ecstasy exposure. BJCP 2005; , In press. [CSA]
- Noda Y. Opiate physical dependence and NMDA receptors. Eur J Pharm 2004; 500:121–128., [CSA], [CROSSREF]
- Pasternak G. Multiple opiate receptors: déjà vu all over again. Neuropharmacology 2004; 47:312–333., [CSA]
- Contet C, Kieffer B, Befort K. Mu opioid receptor: a gateway to drug addiction. Current Opinion in Neurobiology. 2004; 14:370–378., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tarabar A F, Khan Y, Nelson L S, Hoffman R S. Antimony toxicity from the use of tartar emetic for the treatment of alcohol abuse. Vet Hum Toxicol 2004; 46(6):331–333., [PUBMED], [INFOTRIEVE], [CSA]
- Oslin D W, Berrettini W, Kranzler H R, Pettinati H, Gelernter J, Volpicelli J R, O'Brien C P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003; 28(8):1546–1552., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carmen B, Angeles M, Ana M, Maria A J. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004; 99(7):811–828., [CSA], [CROSSREF]
- Mark T L, Kranzler H R, Poole V H, Hagen C A, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. Am J Addict 2003; 12(4):281–294., [PUBMED], [INFOTRIEVE], [CSA]
- Crabbe J C, Phillips T J. Pharmacogenetic studies of alcohol self-administration and withdrawal. Psychopharmacology (Berl) 2004; 174(4):539–560., [CSA]
- Bateman D N, Bain M, Gorman D, Murphy D. QJM 2003; 93:125–132., [CSA], [CROSSREF]
- King L A, Moffat A C. Lancet 1981; 1:387–388., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buckley N A, McManus P R. BMJ 2002; 325:1332–1333., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buckley N A, McManus P R. Drug Saf 1998; 18:369–381., [PUBMED], [INFOTRIEVE], [CSA]
- Bateman D N, Chick J, Good A M, Kelly C A, Masterton G. EJCP 2004; 60:221–224., [CSA], [CROSSREF]
- Geusau A, Abraham K, Geissler K, Sator M O, Stingl G, Tschachler E. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ Health Perspect 2001; 109(8):865–869., [PUBMED], [INFOTRIEVE], [CSA]
- Pelclova D, Fenclova Z, Preiss J, et al. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-tetrachlordibenzo-p-dioxin. Int Arch Occup Environ Health 2002; 75 Suppl:S60–S66., [PUBMED], [INFOTRIEVE], [CSA]
- Suskind R R. Chloracne, “the hallmark of dioxin intoxication”. Scand J Work Environ Health 1985; 11(3 Spec No):165–171., [PUBMED], [INFOTRIEVE], [CSA]
- Caputo R, Monti M, Ermacora E, et al. Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol 1988; 19(5 Pt 1):812–819., [PUBMED], [INFOTRIEVE], [CSA]
- Thomke F, Jung D, Besser R, Roder R, Konietzko J, Hopf H C. Increased risk of sensory neuropathy in workers with chloracne after exposure to 2,3,7,8-polychlorinated dioxins and furans. Acta Neurol Scand 1999; 100(1):1–5., [PUBMED], [INFOTRIEVE], [CSA]
- Michalek J E, Akhtar F Z, Arezzo J C, Garabrant D H, Albers J W. Serum dioxin and peripheral neuropathy in veterans of Operation Ranch Hand. Neurotoxicology 2001; 22(4):479–490., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sweeney M H, Mocarelli P. Human health effects after exposure to 2,3,7,8-TCDD. Food Addit Contam 2000; 17(4):303–316., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beyer W N, et al. Zinc and lead poisoning in wild birds in the tri-state mining district (Oklahoma, Kansas, and Missouri). Arch Environ Contam Toxicol 2005; 48(1):108–117., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buza M, et al. Environmental protection in the Apuseni Mountains: The role of Environmental Non-Governmental Organisations (ENGOs). GeoJournal 2001; 55(2–4):631–653., [CSA], [CROSSREF]
- Jung M C, Thornton I. Environmental contamination and seasonal variation of metals in soils, plants and waters in the paddy fields around a Pb-Zn mine in Korea. Sci Total Environ 1997; 198(2):105–121., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van Green A, et al. A 120 year record of widespread contamination from mining of the Iberian pyrite belt. Geology 1997; 24(4):291–294., [CSA], [CROSSREF]
- Agency for Toxic Substances and Disease Registry ADSTR 1992. US Dept Public Health, Atlanta, Georgia.
- Counter S A, Buchanan L H. Mercury exposure in children. A review. Toxicol Appl Pharmacol 2004; 198:209–230., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clarkson T W. The three modern faces of mercury. Environ Health Perspect 2002; 110:11–23., [PUBMED], [INFOTRIEVE], [CSA]
- Ratcliffe H E, Swanson G M, Fischer L J. Human exposure to mercury: a critical assessment of the evidence of adverse health effects. J Toxicol Environ Health 1996; 49:221–270., [PUBMED], [INFOTRIEVE], [CSA]
- Langworth S, Bjorkman L, Elinder C G, Jarup L, Savlin P. Multidisciplinary examination of patients with illness attributed to dental fillings. J Oral Rehabil 2002; 29(8):705–713., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Childrens' amalgam trial study group. The Childrens' Amalgam trial: design and methods. Control Clin Trials 2003; 24(6):795–814., [CSA], [CROSSREF]
- Yip H K, Li D K, Yau D C. Dental amalgam and human health. Int Dent J 2003; 53:464–468., [PUBMED], [INFOTRIEVE], [CSA]
- Vimy M J, Takahashi Y, and Lorscheider F L. Maternal-fetal distribution of mercury released from dental amalgam fillings. Am J Physiol 1990; 258:939–945., [CSA]
- Drasch G, Schupp I, Hoefl H, Reinke R, Roider G. Mercury burden of human fetal and infant tissues. Eur J Pediatr 1994; 153:607–610., [PUBMED], [INFOTRIEVE], [CSA]
- Morton J, Mason H J, Ritchie K A, White M. Comparison of hair, nails and urine for biological monitoring of low level mercury exposure in dental workers. Biomarkers 2004; 1:47–55., [CSA]
- Ritchie K A, Gilmour W H, MacDonald E B. Health and neuropsychological functioning of dentists exposed to mercury. Occup Environ Med 2002; 59:287–293., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Piikivi L, Hanninen H, Martelin T. Psychological performance and long term exposure to mercury vapours. Scand J Work Environ Health 1984; 10:35–41., [PUBMED], [INFOTRIEVE], [CSA]
- Naleway C, Sakaguchi R, Mitchell E, et al. Urinary mercury levels in US dentists, 1975–1983: review of health assessment programme. J Am Dental Assoc 1985; 111:37–42., [CSA]
- Ede F, Hrakeh S. Ban or regulate? Cost of dental occupational safety from mercury. J Health Care Finance 2003; 30:65–83., [CSA]
- Sutow E J, Hall G C, Maclean C A. Effcetiveness of wet and dry mercury vapour suppressant systems in a faculty of dentistry clinic. J Oral Rehabil 2004; 31:822–826., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Teixera M, Costa M, Carvalho V, Pereira M, Hage E. Bulletin of the Pan American Health Organization 1993; 27:244–253., [CSA]
- Falconer I R, Beresford A M, Runnegar M T. Evidence of liver damage by toxin from a bloom of the blue-green alga, Microcystis aeruginosa. Med J Aust 1983; 1:511–514., [PUBMED], [INFOTRIEVE], [CSA]
- Pouria S, de Andrade A, Barbosa J, et al. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet 1998; 352:21–26., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jochimsen E M, Carmichael W W, An J S, et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med 1998; 338:873–878., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pilotto L, Douglas R, Burch M, et al. Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities. Aust N Z J Public Health 1997; 21:562–566., [PUBMED], [INFOTRIEVE], [CSA]
- Turner P C, Gammie A J, Hollinrake K, Codd G A. Pneumonia associated with contact with cyanobacteria. BMJ 1990; 300:1440–1441., [PUBMED], [INFOTRIEVE], [CSA]
- Salmela J, Lahti K, Hoppu K. Sinileväpitoinen saunavesi voi aiheuttaa oireita ihmisille. Finnish Medical Journal 2001; 56:2891–2895., [CSA]
- Watts W, Fountain J, Reith D M, Herbison P. Clinical utility of an electronic poisons information and clinical decision support tool. Int J Med Info 2003; 71:3–8., [CSA], [CROSSREF]
- Public Health Preparedness and Response to Chemical Incidents in Europe. WHO, Geneva 2002.
- OECD Guiding Principles for Chemical Accident Prevention, Preparedness, and Response. 2nd ed. OECD, Paris 2003.
- Public Health Response to Biological and Chemical Weapons. 2nd ed. WHO, Geneva 2004.
- Public Health and Chemical Incidents. WHO, Cardiff 1999.
- Bowen H J, et al. Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in Europe. J Epidemiol Community Health 2000; 54:870–873., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kupferschmidt H. Epidemy of acute respiratory illness linked to use of waterproofing textile and leather spray. J Toxicol Clin Toxicol 2003; 41:665–666., [CSA]
- de Groot R, et al. Sudden increase of acute respiratory illness after using a spray product to waterproof clothing and shoes. J Toxicol Clin Toxicol 2004; 42:443., [CSA]
- Syndromic surveillance. MMWR 2004; 53 (suppl):1–264., [CSA]
- Foldy S, et al. Syndromic surveillance using regional emergency medicine internet. Ann Emerg Med 2004; 44:242–246., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Persson H E, et al. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 35(3):205–213., [CSA]
- Hawkins D B, Demeter M J, Barnett T E. Caustic ingestion: controversies in management. A review of 214 cases. Laryngoscope 1980; 90:98–109., [PUBMED], [INFOTRIEVE], [CSA]
- Homan C S, Singer A J, Henry M C, et al. Thermal effects of neutralization therapy and water dilution for acute alkali exposure in canines. Acad Emerg Med 1997; 4:27–32., [PUBMED], [INFOTRIEVE], [CSA]
- Homan C S, Singer A J, Thomajan C, et al. Thermal characteristics of neutralization therapy and water dilution for strong acid ingestion: an in-vivo canine model. Acad Emerg Med 1998; 5:286–292., [PUBMED], [INFOTRIEVE], [CSA]
- Mamede R C, Mamede, Filho F V. Treatment of caustic ingestion: an analysis of 239 cases. Dis Esophagus 2002; 15:210–213., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rumack B H, Burrington J D. Caustic ingestions: a rational look at diluents. J Toxicol Clin Toxicol 1977; 11:27–34., [CSA]
- Leape L L. New liquid lye drain cleaners. J Toxicol Clin Toxicol 1974; 7:109–114., [CSA]
- Teichert J, Kern J, Tritschler H J, Ulrich H, Preiss R, Teichert J. Int J Clin Pharmacol Ther 1998; 36(12):625–628., [PUBMED], [INFOTRIEVE], [CSA]
- Hermann R, Ruus P, Preiss R. J Clin Pharm 2003; 43:1257–1267., [CSA], [CROSSREF]
- Jacobsen D, Frederichsen D, Knutsen K M, Sorum Y, Talseth T, Odegaard O R. A prospective study of 1212 cases of acute poisoning: general epidemiology. Hum Toxicol 1984; 3(2):93–106., [PUBMED], [INFOTRIEVE], [CSA]
- Walsh L P, McCormick C, Martin C, Stocco D. Roundup Inhibits Steroidogenesis by Disrupting Steroidogenic Acute Regulatory (StAR) Protein Expression. Envir Health Perspec 2000; 108:769–776., [CSA]
- Levine S L, Farmer D R, Heydens W F, Han Z, Wall C, Papadopoulos V. Non-specific alteration of steroidogenesis in vitro by supra-physiological levels of surfactant; Society of Environmental Toxicology and Chemistry. 22nd annual meeting abstracts 2003
- Bradberry S M, Proudfoot A T, Vale J A. Glyphosate poisoning. Toxicological Reviews 2004; 23. , In press. [CSA]
- Soderlund D M, Clark J M, Sheets L P, et al. Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 2002; 171:3–59., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ray D E, Forshaw P J. Pyrethroid insecticides: poisoning syndromes, synergies and therapy. J Toxicol Clin Toxicol 2000; 38:95–101., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chen S, Zhang Z, He F, et al. An epidemiological study on occupational acute pyrethroid poisoning in cotton farmers. Br J Ind Med 1991; 48:77–81., [PUBMED], [INFOTRIEVE], [CSA]
- He F, Chen S, Tang X, et al. Biological monitoring of combined exposure to organophosphates and pyrethroids. Tox Letters 2002; 134:119–124., [CSA], [CROSSREF]
- Leng G, Lewalter J, Röhrig B, Idel H. The influence of individual susceptibility in pyrethroid exposure. Tox Letters 2002; 134:123–130., [CSA]
- He F, Sun J, Han K, et al. Effects of pyrethroid insecticides on subjects engaged in packaging pyrethroids. Br J Ind Med 1988; 45:548–551., [PUBMED], [INFOTRIEVE], [CSA]
- Zhang Z, Sun J, Chen S, et al. Levels of exposure and biological monitoring of pyrethroids in spraymen. Br J Ind Med 1991; 48:82–86., [PUBMED], [INFOTRIEVE], [CSA]
- Wilks M F. Pyrethroid-induced paresthesia—a central or local toxic effect? J Toxicol Clin Toxicol 2000; 38:103–105., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- He F, Wang S, Liu L, et al. Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol 1989; 63:54–58., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peter J V, John G, Cherian A M. Pyrethroid poisoning. J Assoc Physicians India 1996; 44:343–344., [PUBMED], [INFOTRIEVE], [CSA]
- Yang P Y, Lin J L, Hall A H, et al. Acute ingestion poisoning with insecticide formulations containing the pyrethroid permethrin, xylene and surfactant: a review of 48 cases. J Toxicol Clin Toxicol 2002; 40:107–113., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bateman D N. Management of pyrethroid exposure. J Toxicol Clin Toxicol 2000; 38:107–109., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jones G M, Vale J A. Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review. J Toxicol Clin Toxicol 2000; 38:123–128., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vale J A, Meredith T J, Buckley B M. Paraquat poisoning clinical features and immediate general management. Hum Toxicol 1987; 6:41–47., [PUBMED], [INFOTRIEVE], [CSA]
- Bateman D N. Pharmacological treatments of paraquat poisoning. Hum Toxicol 1987; 6:57–62., [PUBMED], [INFOTRIEVE], [CSA]
- Suntres Z E. Role of antioxidants in paraquat toxicity. Toxicology 2002; 180:65–77., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bradberry S M, Watt B E, Proudfoot A T, Vale J A. Mechanisms of toxicity, clinical features, and management of acute chlorophenoxy herbicide poisoning: a review. J Toxicol Clin Toxicol 2000; 38:111–122., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bradberry S M, Proudfoot A T, Vale J A. Poisoning due to chlorophenoxy herbicides. Toxicol Rev 2004; 23:65–73., [PUBMED], [INFOTRIEVE], [CSA]
- Grover R, Smith A E. Adsorption studies with the acid and dimethylamine forms of 2,4-D and dicamba. Can J Soil Sci 1974; 54:179–186., [CSA]
- Belmouden M, Assabbane A, Ichou Y A. Adsorption characteristics of a phenoxy acetic acid herbicide on activated carbon. J Environ Monit 2000; 2:257–260., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Proudfoot A T, Krenzelok E P, Vale J A. Position paper on urine alkalinization. J Toxicol Clin Toxicol 2004; 42:1–26., [PUBMED], [INFOTRIEVE], [CSA]
- Park J, Darrien I, Prescott L F. Pharmacokinetic studies in severe intoxication with 2,4-D and mecoprop. Proc EAPCCT Meeting 1977; 18:154–155., [CSA]
- Prescott L F, Park J, Darrien I. Treatment of severe 2,4-D and mecoprop intoxication with alkaline diuresis. Br J Clin Pharmacol 1979; 7:111–116., [PUBMED], [INFOTRIEVE], [CSA]
- Durakovic Z, Durakovic A, Durakovic S, Ivanovic D. Poisoning with 2,4-dichlorophenoxyacetic acid treated by hemodialysis. Arch Toxicol 1992; 66:518–521., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cassee F R, Sühnel J, Groten J P, Feron V J. In: Ballantyne B, Marrs T C, Syversen T (eds). General and Applied Toxicology. Macmillan: London 2000; 303–320.
- Fenner-Crisp P A. FQPA Science issues: common mechanism of toxicity and cumulative risk assessment. Regul Toxicol Pharmacol 2000; 31:308–310., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilkinson C F, Christoph G R, Julien E, Kelley J M, Kronenberg J, McCarthy J, Reiss R. Assessing the risks of exposure to multiple chemicals with a common mechanism of toxicity: how to cumulate? Regul Toxicol Pharmacol 2000; 31:30–43., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kallen B. Br J Obstet Gynaecol 1998; 105:877–881., [PUBMED], [INFOTRIEVE], [CSA]
- Lalkin A, et al. Am J Obstet Gynecol 1998; 179:727–730., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ruigomez A, et al. Am J Epidemiol 1999; 150(5):476–481., [PUBMED], [INFOTRIEVE], [CSA]
- Walsh S L. Clin Pharmacol Ther 1994; 55:569–580., [PUBMED], [INFOTRIEVE], [CSA]
- Pirany S. Addiction 2004; 99:978–988., [CSA], [CROSSREF]
- Gal T J. Clin Pharmacol Ther 1989; 45:66–71., [PUBMED], [INFOTRIEVE], [CSA]
- Boyd J. Acta Anaesthesiol Scand 2003; 47:1031–1033., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Appelboam A V, et al. Emerg Med J 2002; 19:594–595., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schmidt L, Dalhoff K. Br J Clin Pharmacol 2001; 51:87–91., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yip L, et al. Crit Care Med 1998; 26:40–43., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chan T Y, Critchley J A. Hum Exp. Toxicol 1994; 13:542–544., [PUBMED], [INFOTRIEVE], [CSA]
- O'Grady J G, Alexander G J, Hayllar K M, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445., [PUBMED], [INFOTRIEVE], [CSA]
- Mery P. Intensive Care Med 1994; 20:119–123., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scherrmann J M. Toxicology 1989; 56:213–222., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bismuth C. Hum Exp Toxicol 1997; 16:602–608., [PUBMED], [INFOTRIEVE], [CSA]
- Rouan S E. Am J Pathol 1990; 137:779–787., [PUBMED], [INFOTRIEVE], [CSA]
- Chappey O N. J Pharmacol Exp Ther 1995; 274:1072–1076., [PUBMED], [INFOTRIEVE], [CSA]
- Terrien N. Toxicol Appl Pharmacol 1990; 104:504–510., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sabouraud A E. Toxicology 1991; 68:121–132., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sabouraud A E. J Pharm Pharmacol 1992; 44:1015–1019., [PUBMED], [INFOTRIEVE], [CSA]
- Sabouraud A E. J Pharmacol Exp Ther 1992; 260:1214–1219., [PUBMED], [INFOTRIEVE], [CSA]
- Sabouraud A E. Drug Metab Dispos 1993; 2:997–1002., [CSA]
- Baud F J. N Engl J Med 1995; 332:642–645., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Baud F J. Arch Toxicol Suppl 1997; 19:271–287., [PUBMED], [INFOTRIEVE], [CSA]
- Buckley N A, Karalliedde L, Dawson A, Senanayake N, Eddleston M. Where is the evidence for treatments used in pesticide poisoning? Is clinical toxicology fiddling while the developing world burns? J Toxicol Clin Toxicol 2004; 42(1):113–116., [PUBMED], [INFOTRIEVE], [CSA]
- Eddleston M, Rajapakshe M, Roberts D, et al. Severe propanil [N-(3,4-dichlorophenyl) propanamide] pesticide self-poisoning. J Toxicol Clin Toxicol 2002; 40(7):847–854., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roberts D M, Karunarathna A, Buckley N A, Manuweera G, Sheriff M H, Eddleston M. Influence of pesticide regulation on acute poisoning deaths in Sri Lanka. Bull World Health Organ 2003; 81(11):789–798., [PUBMED], [INFOTRIEVE], [CSA]
- Buckley N A, Roberts D, Eddleston M. Overcoming apathy in research on organophosphate poisoning. BMJ 2004; 329(7476):1231–1233., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Donovan J W, Jarvie D, Prescott L F, et al. Adverse reactions of N-acetylcysteine and relation to plasma levels. Vet Hum Toxicol 1987; 29:470., [CSA]
- Donovan J W, Corayeb M J, Kulig K W, et al. Adverse reactions to slow infusion of intravenous N-acetylcysteine. Vet Hum Toxicol 1990; 32:347., [CSA]
- Thomas S HL, et al. Hum Exper Toxicol 1997; 16:495–500., [CSA]
- Vale J A, et al. Arch Intern Med 1981; 141:394–396., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prescott L F, et al. Br Med J 1979; 2:1097–1100., [PUBMED], [INFOTRIEVE], [CSA]
- Smilkstein M J, et al. N Engl J Med 1988; 319:1557–1562., [PUBMED], [INFOTRIEVE], [CSA]
- Keays R, et al. Br Med J 1991; 303:1026–1029., [CSA]
- Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkman H. Dialysis against a recycled albumin solution enables the removal of albumin bound toxins. Artif Organs 1993; 17:809–813., [PUBMED], [INFOTRIEVE], [CSA]
- Stange J, Hassanein T I, Mehta R, Mitzner S, Barlett R H. The Molecular Adsorbents Recycling System (MARS) as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective randomized controlled clinical trials and clinical experience from 19 centers. Artif Organs 2002; 26:103–110., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sorkine P, Abraham R B, Szold O, et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29:1332–1336., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sen S, Moorerjee R P, Davies N A, Williams R, Jalan R. Review article: the Molecular Adsorbents Recirculationg System (MARS) in liver failure. Aliment Pharmacol Ther 2002; 16 (Suppl. 5):32–38., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shi Y, He J, Chen S, et al. MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning—a case report. Liver 2002; 22 (Suppl. 2):78–80., [PUBMED], [INFOTRIEVE], [CSA]
- Covic A, Goldsmith D, Gusbeth-Tatomir P, et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver International 2003; 23 (Suppl. 3):21–23., [PUBMED], [INFOTRIEVE], [CSA]
- Faybik P, Hetz H, Baker A, et al. Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver International 2003; 23 (Suppl. 3):28–33., [PUBMED], [INFOTRIEVE], [CSA]
- Koivusalo A M, Yildirim Y, Vakkuri A, Lindgren L Höckerstedt K, Isoniemi H. Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 2003; 47:1145–1150., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sen S, Ytebe L M, Rose C, et al. Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med 2004; 30:496–501., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sen S, Ratnaraj N, Davies N A, et al. Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 2003; 44:265–267., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Watson W A, Litovitz T L, Rodgers G C, et al. 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21:353–421., [PUBMED], [INFOTRIEVE], [CSA]
- Cotter G, Kaluski E, Milo O, et al. LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock. A prospective randomized study. Eur Heart J 2003; 24:1287–1295., [PUBMED], [INFOTRIEVE], [CSA]
- Hickey A R, Wenger T L, Carpenter V P, et al. Digoxin immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational study. J Am Coll Cardiol 1991; 17:590–598., [PUBMED], [INFOTRIEVE], [CSA]
- Megarbane B, Andujar P, Delahaye A, et al. Acute poisonings with membrane stabilising agents: analysis of the predictive parameters of non-responsiveness to conventional therapies. European Association of Poisons Centers and Clinical Toxicologists. J Toxicol Clin Toxicol 2003; 41:553–554., [CSA]
- Albertson T E, Dawson A, de Latorre F, et al. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 37:S78–S90., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Megarbane B, Delhotal B, Tchir M, et al. Toxicokinetic—toxicodynamic relationships in case of flecainide poisonings. European Association of Poisons Centers and Clinical Toxicologists. J Toxicol Clin Toxicol 2004; 42:477–478., [CSA]
- Hochman J A, Sleeper L A, Webb J G, et al for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341:625–634., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- The CREATE-ECLA randomized controlled trial. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005; 293:437–446., [CSA], [CROSSREF]
- Batabasi G, Massetti M, Verrier V, et al. Severe intoxication with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance. Arch Mal Coeur 2001; 94:1386–1392., [CSA]
- Baud F J, Guerrier G, Megarbane B, et al. Prospective assessment of clinical criteria of refractoriness to medical treatment in poisonings with membrane stabilising agents. European Association of Poisons Centers and Clinical Toxicologists. J Toxicol Clin Toxicol 2004; 42:473–474., [CSA]
- Stampfer M J, Willett W C, Colditz G A, et al. A prospective study of postmenopausal estrogen therapy and cardiovascular heart disease. N Engl J Med 1985; 313:1044–1049., [PUBMED], [INFOTRIEVE], [CSA]
- Stampfer M J, Colditz G A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Int J Epidemiol 2004; 33:445–453. , (Published as a reprint of this article which was originally published in 1991). [CSA], [CROSSREF]
- Barrett-Conner E: Postmenopausal estrogen and prevention bias. Ann Int Med 1991; 115:455–456., [CSA]
- Women's Health Initiative Investigators: Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the WHI Randomized Controlled Trial. J Am Med Assoc 2002; 288:321–333., [CSA], [CROSSREF]
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998; 280:605–613., [CSA], [CROSSREF]
- Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. J Am Med Assoc 2002; 288:49–57., [CSA], [CROSSREF]
- Beral V, Banks E, Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360:942–946., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- de Silva H A, Fonseka M MD, Pathmeswaran A, et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet 2003; 361:1935–1938., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. J Toxicol Clin Toxicol 1997; 35:721–741., [CSA]
- Widemann B C, et al. Cancer 2004; 100:2222–2232., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Glynn P. Biochem J 1999; 344:625–631., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson M K. Toxicol Appl Pharmacol 1990; 1:385–399., [CSA], [CROSSREF]
- Lotti M. Muscle and Nerve 2002; 25:492–504., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moretto A, Lotti M J. Neurol Neurosurg Psychiatr 1998; 64:463–468., [CSA]
- Van Tienhoven M, Atkins J, Li Y, Glynn P. J Biol Chem 2002; 277:20942–20948., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sánchez-Santed F, Canadas F, Flores P, Lopez-Grancha M, Cardona D. Long-term functional neurotoxicity of paraoxon and chlorpyrifos: behavioural and pharmacological evidence. Neurotoxicol Teratol 2004; 26:305–317., [CSA], [CROSSREF]
- Rosenstock L, Keifer M, Daniell W E, McConnell R, Claypoole K, Pesticide Health Effects Study Group. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 1991; 338:223–227., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McConnell R, Keifer M, Rosenstock L. Elevated quantitative vibrotactile threshold among workers previously poisoned with methamidophos and other organophosphate pesticides. Am J Ind Med 1994; 25:325–334., [PUBMED], [INFOTRIEVE], [CSA]
- Steenland K, Jenkins B, Ames R G, O'Malley M, Chrislip D, Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health 1994; 84:731–736., [PUBMED], [INFOTRIEVE], [CSA]
- Savage E P, Keefe T J, Mounce L M, Heaton R K, Lewis J A, Burcar P J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health 1988; 43:38–45., [PUBMED], [INFOTRIEVE], [CSA]
- Miranda J, McConnell R, Delgado E, et al. Tactile vibration thresholds after acute poisonings with organophosphate insecticides. Int J Occup Environ Health 2002; 8:212–219., [PUBMED], [INFOTRIEVE], [CSA]
- Miranda J, Lundberg I, McConnell R, et al. Onset of grip- and pinch-strength impairment after acute poisonings with organophosphate insecticides. Int J Occup Environ Health 2002; 8:19–26., [PUBMED], [INFOTRIEVE], [CSA]
- Miranda J, McConnell R, Wesseling C, et al. Muscular strength and vibration thresholds during two years after acute poisoning with organophosphate insecticides. Occup Environ Med 2004; 61:e4., [PUBMED], [INFOTRIEVE], [CSA]
- Delgado E, McConnell R, Miranda J, et al. Central nervous system effects of acute organophosphate poisoning in a two-year follow-up. Scand J Work Environ Health 2004; 30:362–370., [PUBMED], [INFOTRIEVE], [CSA]
- Buchanan D, et al. Estimation of cumulative exposure to organophosphate sheep dips in a study of chronic neurological health effects among United Kingdom sheep dippers. Occup Environ Med 2001; 58:694–701., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cherry N, et al. Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet 2002; 359:763–764., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lockridge O, Masson P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicol 2000; 21:113–126., [CSA]
- Markowitz J S, Gutterman E M, Link B G. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicol 2000; 21:113–126., [CSA]
- Markowitz J S, Gutterman E M, Link B G. Self-reported physical and psychological effects following a malathion pesticide incident. J Occup Med 1986; 28:377–383., [PUBMED], [INFOTRIEVE], [CSA]
- Pilkington A, et al. An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med 2001; 58:702–710., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ray D. Organophosphorus esters: an evaluation of chronic neurotoxic effects. MRC Institute for Environment and Health, 1998.
- Yealy D M, Paris P M, Kaplam R M, et al. The safety of prehospital naloxone administration by paramedics. Ann Emerg Med 1990; 19:902–905., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sporer K A, Firestone J, Isaacs S M. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med 1996; 3:660–667., [PUBMED], [INFOTRIEVE], [CSA]
- Hoffman J R, Schriger D L, Luo J S. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med 1991; 20:246–252., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clarke S F, Dargan P I, Jones A L. Clinical Review: Naloxone in opioid poisoning. Emerg Med J. , In press. [CSA]
- Marcus R, Srivastava P U, Bell D M, et al. Occupational blood contact among prehospital providers. Ann Emerg Med 1995; 25:776–779., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kelly A M, Koutsogiannis Z. Intranasal naloxone for life-threatening opioid toxicity. Emerg Med J 2002; 19:375., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kelly A M, Kerr D, Patrick I, et al. Intranasal naloxone is a safe first-line treatment for patients with respiratory compromise due to suspected opioid poisoning., [CSA]
- Thakore S, Murphy N. The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63–65., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Karim A, Ivatts S, Dargan P, et al. How feasible is it to conform to the European guidelines on administration of activated charcoal? Emerg Med J 2001; 18:390–392., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Isbister G K, Dawson A H, Whyte I M. Feasibility of prehospital treatment with activated charcoal: who could we treat, who should we treat? Emerg Med J 2003; 20:375–378., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Crockett R, Krishel S J, Manoguera A, et al. Prehospital se of activated charcoal: a pilot study. J Emerg Med 1996; 14:335–338., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Spiller H A, Rogers G D. Evaluation of administration of activated charcoal in the home. Pediatrics 2001; 108:E100., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Alaspaa O, Kuisma M J, Hoppu K, et al. Feasibility study on activated charcoal given prehospital by emergency medical systems in acute intoxications. J Toxicol Clin Toxicol 2002; 40:312–313., [CSA]
- He F, et al. Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol 1989; 63:54–58., [CSA]
- Schier J G, Hoffman R S, Nelson L S. Desiccant induced gastrointestinal burns (abstract). J Toxicol Clin Toxicol 2002; 40:627., [CSA]
- Catchings T T, Beamer W C, Lundy L, et al. Adult respiratory distress syndrome secondary to ethylene glycol intoxication. Ann Emerg Med 1985; 14(6):594–596., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gardner T B, Manning H L, Beelen A P, et al. Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal deposition. J Clin Gastroenterol 2004; 38(5):435–439., [PUBMED], [INFOTRIEVE], [CSA]
- Rasic S, Cengic M, Golemac S, et al. Acute renal insufficiency after poisoning with ethylene glycol. Nephron 1999; 81:111–120., [CSA], [CROSSREF]
- Michelot D, Melendez-Howell L M. Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycol Res 2003; 107:131–146., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clark R F, Wethern-Kestner S, Vance M V, et al. Clinical presentation and treatment of black widow spider envenomation: review of 163 cases. Ann Emerg Med 1992; 21(7):782–787., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bagnis R, Kuberski T, Laugier S. Clinical observations on 3,009 cases of ciguatera. Am J Trop Med Hyg 1979; 28(6):1067–1073., [PUBMED], [INFOTRIEVE], [CSA]
- Gillespie N C, Lewis R J, Pearn J H, et al. Ciguatera in Australia: occurrence, clinical features, pathophysiology and management. Med J Aust 1986; 145:584–590., [PUBMED], [INFOTRIEVE], [CSA]
- Lewis R J, Ruff T A. Ciguatera: ecological, clinical and socioeconomic perspectives. Crit Rev Environ Sci Tech 1993; 23(2):137–156., [CSA]
- Pearn J. Neurology of ciguatera. J Neurol Neurosurg Psychiatr 2001; 70:4–8., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Salveron M J, Cantoria M C. Studies on the extracts of two Philipine-grown cultivars of Allium cepa. Planta Medica 1989; 55:662., [CSA]
- Jain R C, Vyas C R. Hypoglycaemia action of onion on rabbits (letter). Br Med J 1974; 2(921):730., [PUBMED], [INFOTRIEVE], [CSA]
- Malpezzi E L, de Freitas J C, Rantin F T. Occurrence of toxins, other than paralysing type, in the skin of Tetraodontiformes fish. Toxicon 1997; 35:57–65., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tambyah P A, Hui K P, Gopalakrishnakone P, Chin N K, Chan T B. Central-nervous-system effects of tetrodotoxin poisoning. Lancet 1994; 343:538–539., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kerdel-Vegas F, Wagner F, Russell P B, et al. Structure of the pharmacologically active factor in the seeds of Lecythis ollaria. Nature 1965; 205:1186–1187.
- Kerdel-Vegas F. The depilatory and cytotoxic action of “Coco De Mono” (Lecythis ollaria) and its relationship to chronic seleniosis. Econ Bot 1966; 20:187–195., [CSA]
- Rochdi M, Sabouraud A, Girre C, et al. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol 1994; 46:351–354., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Armijo J A, Valiente R, Herranz J L. Relation between plasma levels of valproic acid alone and its efficacy and toxicity in pediatric under chronic treatment. Arch Farmacol Toxicol 1981; 7:49–56., [PUBMED], [INFOTRIEVE], [CSA]
- Collaborative Group for Epidemiology of Epilepsy. Adverse reactions to antiepileptic drugs: a follow-up study of patients with chronic antiepileptic drug treatment. Epilepsia 1988; 29:787–793., [CSA]
- Howards C E, Roberts R S, Ely D S, Moye R A. Use of multiple-dose activated charcoal in pheytoin toxicity. Ann Pharmacother 1994; 28:201–203., [CSA]
- Kelly C A, Upex A, Bateman D N. Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. Ann Emerg Med 2004; 44:108–113., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Citrome L, Josianssen R, Bark N, et al. Pharmacokinetics of Aripiprazole and concomitant mood stabilizers [abstract]. Int J Neuropsychopharmacol 2002; 5 (Suppl 1):187., [CSA]
- Mallikaarjun S, Salazar D E, Bramer S L. Pharmacokinetics, tolerability and safety of aripiprazole following single and multiple oral dose administration. Eur Neuropsychopharmacol 2000; 10 (Suppl 3):306., [CSA]
- Keck P E Jr, Mc Elroy S L. Aripirarole a partial dopamine D2 agonist antipsychotic. Expert Opin Investig Drugs 2003; 12 (4):655–662., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sternbach H. Am J Psychiatry 1991; 48:705–713., [CSA]
- Öström M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348:339–340., [CSA]
- Personne M, Persson H, Sjöberg E. Citalopram toxicity. Lancet 1997; 350:518–519., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Olanow C W. Manganese-induced Parkinsonism and Parkinson's Disease. Ann NY Acad Sci 2004; 1012:209–223., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- March, Huang C C, Weng Y H, Lu C S, Chu N S, Yen T C. Dopamine Transporter Binding in Chronic Manganese intoxication. J Neurol 2003; 250(11):1335–1339., [CSA], [CROSSREF]
- Bulpitt C J, Shaw K, Clifton P, Stern G, Davies J B, Reid J L. The symptoms of patients treated for Parkinson's Disease. Clin Neuropharmacol 1985; 8(2):175–183., [PUBMED], [INFOTRIEVE], [CSA]
- Olanow C W, Good P F, et al. Manganese intoxication in the Rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996; 46(2):492–498., [PUBMED], [INFOTRIEVE], [CSA]
- Hawton K, et al. Trends in deliberate self-harm in Oxford 1985–1995. Br J Psychiatr 1997; 171:556–560., [CSA]
- Bialis M C, et al. Changing patterns of self-poisoning in a UK health district. QJM 1996; 89:893–901., [CSA]
- Wynne H, et al. Hum Exp Toxicol 1988; 6: 511–515., [CSA]
- Walsh N, Donohoe E, Tracey J A. Smaller pack size has a positive impact on deliberate paracetamol overdose in Ireland. J Toxicol Clin Toxicol 2004; 42:499 , [abstract]. [CSA]
- Hawton K, Ware C, Mistry H. Paracetamol self-poisoning: characteristics, prevention and harm reduction. Br J Psychiatr 1996; 168:43–48., [CSA]
- Balit C R, Isbister G K, Peat J, Dawson A H, Whyte I M. Paracetamol recall: a natural experiment influencing analgesic poisoning. Med J Aust 2002; 176(4):162–165., [PUBMED], [INFOTRIEVE], [CSA]
- Sheen C L, Dillon J F, Bateman D N, Simpson K J, MacDonald T M. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11(4):329–331., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ford, Delaney, Ling, Erickson. Clinical Toxicology 2001 , Edition. [CSA]
- Ulmeanu, Oraseanu. Acute poisoning in children—diagnosis and treatment. Bucharest, 1995., [CSA]
- Thomas S HL, et al. Presentation of poisoned patient to accident and emergency departments in the North of England. Hum Exper Toxicol 1996; 15:466–470., [CSA]
- Verheij E, van der Greef J, La Vos G, et al. Identification of diuron and four of its metabolites in human postmortem plasma and urine by LC/MS with a moving-belt interface. J Anal Toxicol 1989; 13:8–12., [PUBMED], [INFOTRIEVE], [CSA]
- Van Boven M, Laruelle L, Daenens P. HPLC analysis of diuron and metabolites in blood and urine. J Anal Toxicol 1990; 14:231–234., [PUBMED], [INFOTRIEVE], [CSA]
- Proudfoot A T. Diagnosis and management of acute poisoning 2nd Ed., 1982, Butterworth Heinemann.
- Woollen B H, Mahler D. An improved spot test for paraquat and diquat in biological samples. Clin Chim Acta 1987; 167:225–229., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bismuth C, Hall A H. Paraquat poisoning, 1995, Marcel Dekker.
- Quinio P, et al. Anesthesiology 1995; 83:875., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Modica P A, et al. Can J Anaesth 1992; 39:236–241., [PUBMED], [INFOTRIEVE], [CSA]
- Lawson R, Estrade-Chapellaz E. Intoxication volontaire par le glufosinate. Ann Fr Anesth Réanim 1999; 18:1025–1026., [CSA], [CROSSREF]
- Koyama K, et al. Cardiovascular effects of a herbicide containing glufosinate and a surfactant: in vitro and in vivo analyses in rats. Toxicol Appl Pharmacol 1997; 145:409–414., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Casteels-Van Daele M, Eggermont E, Casaer P, et al. Acute dystonic reactions and long-lasting impaired consciousness associated with oxatomide in children. Lancet 1986; 1(8491):1204–1205., [CSA], [CROSSREF]
- Iwamoto K, Ikeda J, Nito M, et al. Effect of oxatomide, an antiallergic agent, on QT interval in dogs. Arzneim Forsch Drug Res 2001; 51:971–978., [CSA]
- Sesti F, Abbott G W, Wei J, et al. A common polymorphysm associated with antibiotic-induced cardiac arrhythmia. PNAS 2000; 97:10613–10618., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Littmann L, et al. Brugada syndrome and “Brugada sign.” Clinical spectrum with a guide for the clinician. Am Heart J 2003; 145:768–778., [PUBMED], [INFOTRIEVE], [CSA]
- Zareba W, et al. Electrocardiographic findings in patients with diphenhydramine overdose. Am J Cardiol 1997; 80:1168–1173., [PUBMED], [INFOTRIEVE], [CSA]
- Sharma N A, et al. Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. Am J Emerg Med 2003; 21:212–215., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Taboulet P, Baud F J, Bismuth Ch. Clinical features and management of digitalis poisoning—rationale for immunotherapy. J Toxicol Clin Toxicol 1993; 31(2):247–260., [PUBMED], [INFOTRIEVE], [CSA]
- Biddle D A, Datta P, Wells A, et al. Falsely elevated serum digitoxin concentrations due to cross-reactivity of water-extractable digitoxin-like immunoreactivity of Chinese medicine Chan SU: elimination of interference by use of a chemiluminescent assay. Clin Chim Acta 2000; 300:151–158., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miller H C. Cardiac arrest after intravenous pentamidine in an infant. Pediatr Infect Dis J 1993; 12(8):694–696., [PUBMED], [INFOTRIEVE], [CSA]
- Owens R C Jr. QT prolongation with antimicrobial agents: understanding the significance. Drugs 2004; 64(10):1091–1124., [PUBMED], [INFOTRIEVE], [CSA]
- Shannon M W, Haddad L M. The emergenecy management of poisoning. In: Haddad L M. linical management of poisoning and drug overdoes. 3rd ed., Phladelphia: Saunders Company, 1998: 2–3.
- Pentel P R, Keyler D E, Haddad L M. Tricyclic antidepressants and selective serotonin reuptake inhibtors. In: Haddad L M. Cilinical management of poisoning and drug overdose. 3rd ed., Philadelphia: Saunders Company, 1998: 437–451.
- Ellenhorn M J. Ellenhorn's medicial toxicology diagnosis and treatment of human poisoning, 2nd ed., Baltimore: Williams & Wilkins Company, 1997: 624–639.
- William Z P, Leo E H. Antidepressant agents. In: Katzung B G, Basic and clinical pharmacology, 7th ed., Norwalk: Appleton & Lange Company, 1998: 483–495.
- Boehnert M T, Lovejoy F H. Value of the QRS duration versus the serum drug level in prediciting seizures and venticular arrhythmias after an acute overdoes of tricyclic antidepressant. N Engl J Med 1985; ??:373–474., [CSA]
- Niemann J T, Bessen H A, Rothstein R J, Lake M M. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57:1154–1159., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lieblet E L, Francis P D, Woolf A D: ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricrcylic antidepressant toxicty. Ann Emery Med 1995; 26:195–201., [CSA], [CROSSREF]
- Caravati E M, Bossart D J. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxciol Clin Toxicol 1991; 29:31–43., [CSA]
- Dawson A H, Whyte I. Br J Clin Pharmacol 1999; 48:278–283., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yuan T H, et al. J Toxicol Clin Toxicol 1999; 37:463–474., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Flanigan M J, Von Brecht J, Freeman R M, Lim V S. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 1987; 9(2):147–153., [PUBMED], [INFOTRIEVE], [CSA]
- McKinney P. Acute elevation of blood lead levels within hours of ingestion of large quantities of lead shot. J Toxicol Clin Toxicol 2000; 38:435–440., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McNutt T K Chambers-Emerson J A, Dethlefsen M, Shah R. Bite the bullet: Lead poisoning after ingestion of 206 lead bullets. Vet Hum Toxicol 2001; 43:288–289., [PUBMED], [INFOTRIEVE], [CSA]
- Perry H, Shannon M W. Acetaminophen. In: Haddad L M, Shannon M W, Winchester J F. Clinical management of poisoning and drug over dose. Philadelphia: WB Saunders; 1998: 664–673.
- Shannon M W, Haddad L M. The emergency management of poisoning. In: Haddad L M, Shannon M W, Winchester J F. Clinical management of poisoning and drug over dose. Philadelphia: WB Saunders; 1998: 2–28.
- Schmidt L E, Dalhoff K. The Risk factor in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2000; 51:87–91., [CSA], [CROSSREF]
- Mant T GK, Tempowski J H, Volans G N, Talbot J CC. Adverse reactions to acetylcysteine and effects of overdose. Br Med J 1984; 289:217–219., [CSA]
- Vale J A, Proudfoot A T. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346:547–552., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Flanagan R J, Meredith T J. Use of N-acetylcysteine in clinical toxicology. Am J Med 1991; 91:131–139., [CSA], [CROSSREF]
- Reynard K, Riley A, Walker B E. Respiratory arrest after N-acetylcysteine for paracetamol overdose. Lancet 1992; 340:675., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ho S W-C, Beilin L J. Asthma associated with N-acetylcysteine infusion and paracetamol poisoning. Report of two cases. Br Med J 1983; 287:876–877., [CSA]
- Bailey B, McGuigan M A. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31:710–715., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sayes C, Fortner J, et al. The differential Cytotoxicity of water-soluble fullerenes. Nano Letters 2004. , In press. [CSA]
- Prylutaskyy Y, Yashcuk V, et al. Biophysical studies of fullerene-based composite for bio-nanotechnology. Material Science and Engineering C 2003; 23:109–111., [CSA], [CROSSREF]
- Dugan L, Lovett E, et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism and Related Disorders 2001; 7:243–246., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ueng T, Kang J, et al. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicology Letters 1997; 93:29–37., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stacchiotti A, et al. Histol Histopathol 2004; 19:1209–1218., [PUBMED], [INFOTRIEVE], [CSA]
- Sener G, et al. Pharmacol Toxicol 2003; 93:290–296., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Satoh M, et al. J Pharmacol Exp Therap 1997; 283:1529–1533., [CSA]
- Nath K, et al. Kidney Int 1996; 50:1032–1043., [PUBMED], [INFOTRIEVE], [CSA]
- Peace M R, Tarnai L D, Poklis A. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J Anal Toxicol 2000; 24:589–594., [PUBMED], [INFOTRIEVE], [CSA]
- Long H, et al. Vet Hum Toxicol 2003; 45:149., [PUBMED], [INFOTRIEVE], [CSA]
- Meatherall R, et al. J Anal Toxicol 2003; 27:313–317., [PUBMED], [INFOTRIEVE], [CSA]
- Brush D E, et al. J Toxicol Clin Toxicol 2004; 42(2):191–195., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cracowski J L, Mallaret M, Vanzetto G. Myocardial Infarction Associated with Buprenorphine. Ann Intern Med 1999; 130(6):537., [CSA]
- Maloney C. Talc retinopathy. OT 2002; 42(24):34–36., [CSA]
- Filley C M, Kleinschmidt-DeMasters B K. Toxic leukoencephalopathy. N Engl J Med 2001; 345(6):425–432., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- National Board of Health. Report on alcohol, drugs of abuse and tobacco. National Board of Health, Copenhagen 2002.
- ESPAD. The 1999 ESPAD report: Alcohol and other drug use among students in 26 European countries. , www.ESPAD.org. [CSA]
- Mariani P J. Seizure associated with low-dose naloxone. Am J Emerg Med 1989; 7(1):127–129., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bartsch C, et al. 2003 Munchausen syndrome by proxy (MSBP) an extreme form of child abuse with a special forensic challenge. Forens Sci Internat 137:147–151., [CSA], [CROSSREF]
- Wax, P M. Antiseptics, Disinfectants, and Sterilants In: Goldfrank L R, Flomenbaum N E, Lewin N A, et al (eds): Goldfrank's Toxicologic Emergencies, 7th ed., New York, McGraw Hill, 2002, p. 1283.
- Hall V A, Guest J M. Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis. Am J Crit Care 1992; 1:19–25., [PUBMED], [INFOTRIEVE], [CSA]
- Baskin S I, Porter D W, Rockwood G A, et al. In vitro and in vivo comparison of sulphur donors as antidotes to acute cyanide intoxication. J Appl Toxicol 1999; 19:173–183., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wyeth. Rapamune (sirolimus) prescribing information. Vol. 2004. Philadelphia, PA, 2004.
- Al-Bekairi A. Sirolimus. Drugdex. Vol. 2004. Vol. 122 ed: Thomson Micromedex, 2004.
- Colaluca D M TT, Yeh T L. Ciprofloxacin. Drugdex. Vol. 122: Thomson Micromedex, 2004.
- Pham P T, Pham P P, Danovitch G M, et al. Sirolimus-associated pulmonary toxicity. Transplantation 2004; 77:1215–1220., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McElhatton P R, et al. Pharm J 2000; 265:863–865., [CSA]
- Oncken C A, Kranzler H R. Drug Alcohol Rev 2003; 22:191–202., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bupropion Pregnancy Registry Interim Report. 31st August, 2003.
- Molyneux A. BMJ 2004; 238:454–456., [CSA], [CROSSREF]
- Scialli A R, et al. Drugs During Pregnancy and Lactation. Ed. Schaefer C. Elsevier 2001.
- Erickson S J, Duncan A. Clonidine poisoning—an emerging problem: epidemiology, clinical features, management and preventative strategies. J Paediatr Child Health 1998; 34:280–282., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Anon. Yasmin advert withdrawn—why and how. Drug Ther Bull 2003; 41(3):17–18., [CSA]
- Edmond M B. National and Intrenational Surveillace Systems for nosocomial infections. In: Wenzel R P, ed. Prevention and control of nosocomial infections. Philadelphia: Lippincot Williams & Wilkins; 2003. p. 109–119.
- Centers for Disease Control and Prevention. Monitoring hospital acquired infections to promote patient safety—Unated States, 1990–1999. MMWR 2000; 49:149–153., [CSA]
- Weber D J, Raasch R, Rutala W A. Nosocomial infections in the ICU. Chest 1999; 115:34S–41S., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Richards M J, Edwards J R, Culver D H, Gaynes R P the National Nosocomial Infections Surveillance System. Nosocomila infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21:510–515., [PUBMED], [INFOTRIEVE], [CSA]
- Kwong L, Sohal R S. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys 1998; 350(6):118–126., [PUBMED], [INFOTRIEVE], [CSA]
- Sahlin K, Gorski J, Edstrom L. Influence of ATP turnover and metabolite changes on IMP formation and glycolysis in rat skeletal muscle. Am J Physiol 1990; 259:C409–C412., [PUBMED], [INFOTRIEVE], [CSA]
- Hall A H, Smolinske S C, Kulig K W, Rumack B H. Ibuprofen overdose-a prospective study. West J Med 1988; 148(6):653–656., [PUBMED], [INFOTRIEVE], [CSA]
- Hall A H, Smolinske S C, Stover B. Ibuprofen overdose in adults. J Toxicol Clin Toxicol 1992; 30:23–37., [PUBMED], [INFOTRIEVE], [CSA]
- McElwee, N E, Veltri J C, Bradford D C, Rollins D E. A prospective-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted. Ann Emerg Med 1990; 19(6):657–662., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Collins, et al. Ann Rev Pharmacol Toxicol 1999; 39:399–430., [CSA], [CROSSREF]
- Wanju, et al. J Am Acad Dermatol 1992; 26:599–606., [CSA]